Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just an out of PTSC touch thought...

...thats exactly my point of view. And to substantiate the thesis that Crossflo preferred shares to cash, one just has to consider the share-cash ratio. Isn't it just the principle of free market economy to earn as much as possible. What I think is that Crossflo accepted a deal like this because for them its the most profitable way.

Jerry

Share
New Message
Please login to post a reply